New therapies for multiple myeloma are dramatically improving prognosis and extending survival. Better disease control is prolonging remission and allowing patients to live without any sign of disease ...

Over one-third of MS patients do not fully recover post-relapse, with severity as the strongest predictor of incomplete recovery. Relapse-associated worsening (RAW) is crucial in understanding ...

John F. Kelly, PhD, of the Recovery Research Institute and Department of Psychiatry at Mass General Brigham, is the lead author of a paper published in Frontiers in Public Health, “Long-term relapse: ...

Recovery from bulimia nervosa isn’t always a straight path. It’s common to experience lapses or relapses along the way. These setbacks don’t mean failure — they’re opportunities to learn and ...

Ublituximab shows five year relapse reduction and disability benefits in multiple sclerosis, supporting early high efficacy ...

Substance abuse treatment is a complex and multifaceted journey, and one of the most effective tools in this process is group therapy. Whether you or a loved one is seeking help, learning a few group ...

Disability progression independent of relapse activity (PIRA) -- sometimes referred to as silent progression -- is a key integrating concept in the contemporary view of multiple sclerosis (MS). "The ...

Relapse isn’t a failure. It’s a signal. It tells us that something deeper is still driving our old behaviors. For decades, I’ve studied the science of addiction, relapse, and behavior change through ...

Of 924 patients included, 148 (16%) patients relapsed during a median follow-up of 6.3 years. Invasion of the testicular hilum (rete testis and hilar soft tissue), lymphovascular invasion, and ...